US Company P (about 40-43%), Germany (Europe) Company P (about 20%), Japanese Company C (about 18-20%), which occupy more than 80% of the global market, 3 companies requested detailed data with great interest in ACPi and AACPi technology and usefulness, and are faithfully providing information on the progress of the company. Among these, we would like to close the contract with the United States and Germany by the first half of 2021. We intend to close the contract with Japan by the end of 2021 or 2022 due to permission and circumstances in Japan.

According to German partner information, a smart system that provides treatment information for doctors, pharmacists, and home care shops is widely used in the United States, but Germany and Europe have not yet been introduced. Since Germany and Japan use a number of HIS programs, HIS-linked AACPi and ACPi intend to cooperate with domestic and foreign related program solution companies so that they can be linked with local HIS programs to enter these countries.

As mentioned in the Anyfusion Platform business, HIS-linked ACPi and AACPi are considered to be more absolutely necessary products in the market of advanced countries where labor costs are high, and manual ACPi is considered to be appropriate in demand in many countries where labor costs are low.

We are also exchanging information and conducting market research with Saudi Arabia and Iran, and Since Saudi Arabia registers Anyfusion pump with SFDA, when AACPi and ACPi are released, we expect to contract and deliver them as soon as possible. The Iranian partner has informed the CSTD that it is preparing to land in Iran and will be landing in the near future. If Iranian partners also supply CSTD, they are expected to quickly recognize the need for ACPi and AACPi, which is expected to help them enter the Iranian market.

Although We are limited in publicity because all conferences and exhibitions at domestic and abroad have been canceled due to COVID-19, existing customers that are importing EZ Regular is expecting Anyfusion platform business (ACPi and AACPi) to expand the business area to meaningful items in the pharmaceutical injection field based on rapid market identification and information.

We plan to lead the market after COVID-19 by preparing thoroughly and promptly.

Thank you.